MoneyWorks4Me

Hikal - Quaterly Results

26 Oct 2021 Evaluate
The sales for the September 2021 quarter moved up 26.12% to Rs. 4690.60 millions as compared to Rs. 3719.20 millions during the corresponding quarter last year.Profit for the quarter ended September 2021 rises by 63.45% to Rs. 440.50  millions from Rs. 269.50 millions.The company reported a good operating profit of 917.60 millions compared to 707.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 4690.60 3719.20 26.12 9258.40 7246.90 27.76 17204.40 15072.60 14.14
Other Income 8.70 9.50 -8.42 40.50 15.90 154.72 49.80 37.00 34.59
PBIDT 917.60 707.20 29.75 1906.60 1239.00 53.88 3278.70 2768.50 18.43
Interest 79.60 85.00 -6.35 159.50 181.80 -12.27 362.00 524.20 -30.94
PBDT 838.00 622.20 34.68 1747.10 1057.20 65.26 2916.70 2090.30 39.53
Depreciation 242.00 211.70 14.31 467.60 418.80 11.65 852.40 824.60 3.37
PBT 596.00 410.50 45.19 1279.50 638.40 100.42 2064.30 1265.70 63.10
TAX 155.50 141.00 10.28 334.00 218.90 52.58 732.80 421.40 73.90
Deferred Tax -4.70 -4.30 9.30 -15.10 -6.70 125.37 -62.70 74.40 -184.27
PAT 440.50 269.50 63.45 945.50 419.50 125.39 1331.50 844.30 57.70
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 19.56 19.01 2.88 20.59 17.10 20.45 19.06 18.37 3.75
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..